Where Endothelin-1 is reported
Also listed as: Vasoactive peptide
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Hypertension | ↑ elevated | patients with moderate to severe hypertension vs. normotensive individuals | moderate to severe hypertension | Iglarz et al. 2003 |
| Long COVID | ↑ elevated | healthy controls | Vasoconstriction, POTS | Thomas et al. 2024 |
Frequently asked questions
In which conditions is Endothelin-1 altered?
In the OSMF atlas Endothelin-1 is reported in Hypertension, Long COVID. It is elevated in 2 across 2 entries.
Does Endothelin-1 point to one specific diagnosis?
No. Because Endothelin-1 changes in several conditions (Hypertension, Long COVID), an abnormal result cannot identify which condition, if any, is present. It must be interpreted with symptoms, history and other tests.
What is the LOINC code for Endothelin-1?
Entries in this atlas use LOINC 49867-5. LOINC codes identify the laboratory observation so results can be compared across systems.
Is one abnormal Endothelin-1 result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.